Yaping Zhang
20 Xisi Road
Nantong, 226001, China
Nantong, 226001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Management of diffuse large B‑cell lymphoma in older adults: current strategies and emerging directions.
Journal: Therapeutic advances in medical oncology
Published: January 13, 2026
A multicenter retrospective study on the clinicopathological features, genetic variant profiles and prognosis of patients with previously untreated Diffuse large B-cell lymphoma
Journal: Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
Published: November 13, 2025
rWTC-MBTA Vaccine, Alone and Enhanced with Anti-PD1, Elicits Immune Responses against CNS and Peripheral B-Cell Lymphoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 25, 2025
Indolent peripheral T-cell lymphoma resembling Kimura's disease: a new variant of T-cell Lymphoma?
Journal: Leukemia research reports
Published: March 09, 2025
Next-generation Bruton tyrosine kinase inhibitors and degraders in the treatment of B-cell malignancies: advances and challenges.
Journal: Annals of hematology
Published: February 21, 2025
SSRP1/SLC3A2 Axis in Arginine Transport: A New Target for Overcoming Immune Evasion and Tumor Progression in Peripheral T-Cell Lymphoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 26, 2024
The Role of MicroRNAs, CircRNAs, and LncRNAs in Chronic Lymphocytic Leukemia.
Journal: Current pharmaceutical design
Published: October 17, 2024
Single-cell sequencing in diffuse large B-cell lymphoma: C1qC is a potential tumor-promoting factor.
Single-cell sequencing in diffuse large B-cell lymphoma: C1qC is a potential tumor-promoting factor.
Journal: International immunopharmacology
Published: June 07, 2024
Cell-free chromatin state tracing reveals disease origin and therapy responses.
Journal: Nature
Published: March 18, 2024
LILRB4 regulates multiple myeloma development through STAT3-PFKFB1 pathway.
Journal: Cell death & disease
Published: January 21, 2024
Corrigendum to "Single-cell RNA sequencing in double-hit lymphoma: IMPDH2 induces the progression of lymphoma by activating the PI3K/AKT/mTOR signaling pathway" [Int. Immunopharmacol. 125(Part A) (2023) 111125].
Journal: International immunopharmacology
Published: December 02, 2023
Last Updated: 09/26/2026